Diagnostic imaging techniques play an important role in the diagnosis and management of patients with inflammatory bowel diseases (IBDs). The approach should be guided by considerations of diagnostic accuracy, concerns about patient exposure to ionizing radiation, local expertise and tolerance of the endoscopic and/or imaging technique. In regard to the clinical diagnostic value (sensitivity, specificity and accuracy), no significant differences exist between CT and MRI for the evaluation of the extent of inflammation, stricturing, penetrating disease or extraluminal complications such as abscesses. Due to the absence of radiation exposure, MRI of the intestine is recommended as the first-line imaging modality in patients with suspected or established IBD. The focus of this review is the latest developments in MRI techniques to detect IBDs. Specifically, the use of new indices for the grading of inflammation or assessing bowel damage as well as innovative experimental approaches such as diffusion-weighted imaging or magnetization-transfer MRI to evaluate and quantify the degree of intestinal inflammation and fibrosis in stricturing Crohn's disease are discussed.

1.
Panes J, Bouhnik Y, Reinisch W, et al: Imaging techniques for assessment of inflammatory bowel disease: joint ECCO and ESGAR evidence-based consensus guidelines. J Crohns Colitis 2013;7:556-585.
2.
Herfarth H: Update imaging in inflammatory bowel diseases. Dig Dis 2013;31:345-350.
3.
Panés J, Bouzas R, Chaparro M, et al: Systematic review: the use of ultrasonography, computed tomography and magnetic resonance imaging for the diagnosis, assessment of activity and abdominal complications of Crohn's disease. Aliment Pharmacol Ther 2011;34:125-145.
4.
Horsthuis K, Bipat S, Bennink RJ, et al: Inflammatory bowel disease diagnosed with US, MR, scintigraphy, and CT: meta-analysis of prospective studies. Radiology 2008;247:64-79.
5.
Qiu Y, Mao R, Chen BL, et al: Systematic review with meta-analysis: magnetic resonance enterography vs. computed tomography enterography for evaluating disease activity in small bowel Crohn's disease. Aliment Pharmacol Ther 2014;40:134-146.
6.
Schreyer AG, Hoffstetter P, Daneschnejad M, et al: Comparison of conventional abdominal CT with MR-enterography in patients with active Crohn's disease and acute abdominal pain. Acad Radiol 2010;17:352-357.
7.
Church PC, Turner D, Feldman BM, et al: Systematic review with meta-analysis: magnetic resonance enterography signs for the detection of inflammation and intestinal damage in Crohn's disease. Aliment Pharmacol Ther 2015;41:153-166.
8.
Rimola J, Ordás I, Rodríguez S, et al: Imaging indexes of activity and severity for Crohn's disease: current status and future trends. Abdom Imaging 2012;37:958-966.
9.
Rimola J, Ordás I, Rodriguez S, et al: Magnetic resonance imaging for evaluation of Crohn's disease: validation of parameters of severity and quantitative index of activity. Inflamm Bowel Dis 2011;17:1759-1768.
10.
Rimola J, Rodriguez S, García-Bosch O, et al: Magnetic resonance for assessment of disease activity and severity in ileocolonic Crohn's disease. Gut 2009;58:1113-1120.
11.
Hordonneau C, Buisson A, Scanzi J, et al: Diffusion-weighted magnetic resonance imaging in ileocolonic Crohn's disease: validation of quantitative index of activity. Am J Gastroenterol 2014;109:89-98.
12.
Ordás I, Rimola J, Rodríguez S, et al: Accuracy of magnetic resonance enterography in assessing response to therapy and mucosal healing in patients with Crohn's disease. Gastroenterology 2014;146:374-382.e1.
13.
Friedrich C, Fajfar A, Pawlik M, et al: Magnetic resonance enterography with and without biphasic contrast agent enema compared to conventional ileocolonoscopy in patients with Crohn's disease. Inflamm Bowel Dis 2012;18:1842-1848.
14.
Pariente B, Mary JY, Danese S, et al: Development of the Lémann index to assess digestive tract damage in patients with Crohn's disease. Gastroenterology 2015;148:52-63.e3.
15.
Ananthakrishnan AN, Hanauer SB: The Holy Grail, or only half way there? Gastroenterology 2015;148:8-10.
16.
Kim KJ, Lee Y, Park SH, et al: Diffusion-weighted MR enterography for evaluating Crohn's disease: how does it add diagnostically to conventional MR enterography? Inflamm Bowel Dis 2015;21:101-109.
17.
Akashi M, Nakahusa Y, Yakabe T, et al: Assessment of aggressiveness of rectal cancer using 3-T MRI: correlation between the apparent diffusion coefficient as a potential imaging biomarker and histologic prognostic factors. Acta Radiol 2014;55:524-531.
18.
Buisson A, Joubert A, Montoriol PF, et al: Diffusion-weighted magnetic resonance imaging for detecting and assessing ileal inflammation in Crohn's disease. Aliment Pharmacol Ther 2013;37:537-545.
19.
Kiryu S, Dodanuki K, Takao H, et al: Free-breathing diffusion-weighted imaging for the assessment of inflammatory activity in Crohn's disease. J Magn Reson Imaging 2009;29:880-886.
20.
Neubauer H, Pabst T, Dick A, et al: Small-bowel MRI in children and young adults with Crohn disease: retrospective head-to-head comparison of contrast-enhanced and diffusion-weighted MRI. Pediatr Radiol 2013;43:103-114.
21.
Oto A, Kayhan A, Williams JT, et al: Active Crohn's disease in the small bowel: evaluation by diffusion weighted imaging and quantitative dynamic contrast enhanced MR imaging. J Magn Reson Imaging 2011;33:615-624.
22.
Oto A, Zhu F, Kulkarni K, et al: Evaluation of diffusion-weighted MR imaging for detection of bowel inflammation in patients with Crohn's disease. Acad Radiol 2009;16:597-603.
23.
Oussalah A, Laurent V, Bruot O, et al: Diffusion-weighted magnetic resonance without bowel preparation for detecting colonic inflammation in inflammatory bowel disease. Gut 2010;59:1056-1065.
24.
Ream JM, Dillman JR, Adler J, et al: MRI diffusion-weighted imaging (DWI) in pediatric small bowel Crohn disease: correlation with MRI findings of active bowel wall inflammation. Pediatr Radiol 2013;43:1077-1085.
25.
Tielbeek JA, Ziech ML, Li Z, et al: Evaluation of conventional, dynamic contrast enhanced and diffusion weighted MRI for quantitative Crohn's disease assessment with histopathology of surgical specimens. Eur Radiol 2014;24:619-629.
26.
Rieder F, Zimmermann EM, Remzi FH, et al: Crohn's disease complicated by strictures: a systematic review. Gut 2013;62:1072-1084.
27.
Perlman SB, Hall BS, Reichelderfer M: PET/CT imaging of inflammatory bowel disease. Semin Nucl Med 2013;43:420-426.
28.
Rimola J, Planell N, Rodríguez S, et al: Characterization of inflammation and fibrosis in Crohn's disease lesions by magnetic resonance imaging. Am J Gastroenterol 2015;110:432-440.
29.
Ihalainen TM, Lönnroth NT, Peltonen JI, et al: MRI quality assurance using the ACR phantom in a multi-unit imaging center. Acta Oncol 2011;50:966-972.
30.
Al-Hawary M, Zimmermann EM: A new look at Crohn's disease: novel imaging techniques. Curr Opin Gastroenterol 2012;28:334-340.
31.
Shah B, Anderson SW, Scalera J, et al: Quantitative MR imaging: physical principles and sequence design in abdominal imaging. Radiographics 2011;31:867-880.
32.
Adler J, Rahal K, Swanson SD, et al: Anti-tumor necrosis factor α prevents bowel fibrosis assessed by messenger RNA, histology, and magnetization transfer MRI in rats with Crohn's disease. Inflamm Bowel Dis 2013;19:683-690.
33.
Adler J, Swanson SD, Schmiedlin-Ren P, et al: Magnetization transfer helps detect intestinal fibrosis in an animal model of Crohn disease. Radiology 2011;259:127-135.
34.
Dillman JR, Swanson SD, Johnson LA, et al: Comparison of noncontrast MRI magnetization transfer and T2-weighted signal intensity ratios for detection of bowel wall fibrosis in a Crohn's disease animal model. J Magn Reson Imaging 2014, Epub ahead of print.
35.
Pazahr S, Blume I, Frei P, et al: Magnetization transfer for the assessment of bowel fibrosis in patients with Crohn's disease: initial experience. MAGMA 2013;26:291-301.
36.
Helvie K, Dhanani M, Al-Hawary MM, et al: Magnetization-transfer MRI as a non-invasive method of assessing fibrotic intestinal strictures in patients with Crohn's disease. Gastroenterology 2013;144:S86.
You do not currently have access to this content.